Navigation Links
Ghengis Khan wonder berry could conquer heart disease

Berries taken since the time of Ghengis Khan could form the basis of the next big thing in heart health. Sea buckthorn is a known source of biologically active chemicals and is used in Tibet, Mongolia, China and Russia for health drinks and various cosmetics. Juice extracted using current methods is of poor quality, but scientists in India have developed a highly efficient technique to extract large quantities of cholesterol-lowering compounds. Two companies have shown interest in the process including one based in Mongolia.

In research due to be published this week in SCI's Journal of the Science of Food and Agriculture (DOI 10.1002/jsfa2620) Dr C Arumyghan and his team at the Regional Research Laboratory, Trivandrum report the implementation of a new process which retains more than 40% of polyphenols - the same beneficial chemicals found in red wine, 50% of flavonoids and 70% of vitamin C present in the pulp of the red berries.

Antioxidants in the berries inhibit so-called 'bad' LDL cholesterol oxidisation, which could provide a new weapon to fight cardiovascular disease. When LDL cholesterol is oxidized, it sticks to the lining of blood vessels. Consuming the berries in food or drinks is expected to prevent the arteries from clogging up.

Arumughan is confident that this technology had great potential, saying "No previous report has shown efficiency matching ours". Arumughan's team have unlocked the nutrients by applying novel processing technique for the first time. The key to their success is using continuous high speed centrifugation (spinning) to separate the juice and the solid sludge.
'"/>

Source:Society of Chemical Industry


Page: 1

Related biology news :

1. Give thanks for the cranberry, say dental researchers
2. Strawberry daiquiris -- the extra-healthy cocktail?
3. Protein discovery could unlock the secret to better TB treatment
4. Tiny particles could solve billion-dollar problem
5. First atlas of key brain genes could speed research on cancer, neurological diseases
6. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
7. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
8. How the environment could be damaging mens reproductive health
9. Dead zone area in Gulf could be increasing, researchers say
10. Growth in biomass could put US on road to energy independence
11. Nano-bumps could help repair clogged blood vessels
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/20/2016)... -- The rising popularity of mobility services such ... significant interest in keyless access systems. Following the ... (BLE), biometrics and near-field communication (NFC) are poised ... technologies in the automotive industry. This evolution from ... opens the market to specialist companies such as ...
(Date:12/16/2016)... Dec. 16, 2016   IdentyTechSolutions America LLC ... products and solutions and a cutting-edge manufacturer of ... it is offering seamless, integrated solutions that comprise ... products. The solutions provide IdentyTech,s customers with combined ... facilities from crime and theft. "We ...
(Date:12/15/2016)... VANCOUVER, Canada and BADEN-BADEN, Germany ... Solutions, a leading global financial services provider, today announced an ... in passive behavioural biometrics, to join forces. The partnership will ... fraud mitigation strategies in compliance with local data protection regulation. ... In ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... ... 12, 2017 , ... MEXICO’S FIRST SPINAL ... announces the successful outcome of the first lumbar fusion procedure in Mexico ... Inc.) has partnered with Mexico-based medical product company BioMedical Technologies to bring ...
(Date:1/12/2017)... , January 12, 2017 The ... world,s biggest facility for producing mycorrhizae. The Centre for ... tapping potential of mycorrhizae and developed a technology that ... ... The TERI facility has a ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical ... promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. ... Twenty-seven percent of these heavily pretreated patients saw clinical benefit from the drug, ...
(Date:1/11/2017)... ... January 11, 2017 , ... With sepsis ... systems more than $23.7 billion, healthcare systems are looking to provide better ... most common sepsis-causing pathogens are bacteria and the yeast pathogen Candida, which can ...
Breaking Biology Technology: